Paul Moore
Company: MacroGenics
Job title: Vice President - Immunology & Cell Biology
Seminars:
Panel Discussion: Tug of War: Understanding How LAG-3 & PD-1 Interplay with One Another 9:30 am
What are the key learnings and questions that have come out of the RELATIVITY-047 Trial? How do we rationally test PD-1/LAG-3 combinations in a way that further elucidates their interplay with one another? Will our understanding grow more in vivo with mice, or in the clinic?Read more
day: Day Two
Advancing Tebotelimab, a Bispecific PD-1 x LAG-3 DART Molecule, From Concept to Clinical Assessment 11:30 am
Optimizing molecular design to enable combinatorial PD-1 and LAG-3 blockade Proof of concept clinical studies in DLBCL and various solid tumors Translational biology and clinical biomarker analyses guiding avenues of developmentRead more
day: Day One